Cargando…

Ginseng-Related Drug-Induced Liver Injury

Ginseng is commonly used as a medicinal herb for memory and concentration and general well-being. Drug-induced liver injury (DILI) is one of the most challenging disorders and trending events in the United States which are related to body building and weight loss supplements. Currently, herbal and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Kyawzaw, Lin, Aung Naing, Linn, Sandar, Hlaing, Pwint Phyu, Vasudevan, Viswanath, Reddy, Madhavi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120378/
https://www.ncbi.nlm.nih.gov/pubmed/30186097
http://dx.doi.org/10.1159/000490525
_version_ 1783352258492104704
author Lin, Kyawzaw
Lin, Aung Naing
Linn, Sandar
Hlaing, Pwint Phyu
Vasudevan, Viswanath
Reddy, Madhavi
author_facet Lin, Kyawzaw
Lin, Aung Naing
Linn, Sandar
Hlaing, Pwint Phyu
Vasudevan, Viswanath
Reddy, Madhavi
author_sort Lin, Kyawzaw
collection PubMed
description Ginseng is commonly used as a medicinal herb for memory and concentration and general well-being. Drug-induced liver injury (DILI) is one of the most challenging disorders and trending events in the United States which are related to body building and weight loss supplements. Currently, herbal and dietary supplementation is the second most common cause of DILI. Here, we report on a 45-year-old healthy Chinese woman who presented with dull intermittent left upper quadrant abdomen pain for a month. Upon thorough history taking, she had been taking ginseng tea and supplementation for her menopausal symptoms for almost 3 months. Physical examination was unremarkable except mild tenderness in left upper quadrant of the abdomen. Liver function test showed aspartate transaminase (AST) 717 U/L, alanine transaminase (ALT) 343 U/L, total bilirubin 5 mg/dL, direct bilirubin 3.3 mg/dL, alkaline phosphatase 182 U/L, with international normalized ratio (INR) 1.2. Prior liver enzymes (6 months earlier) showed AST 21 U/L, ALT 18 U/L, total bilirubin 0.8 mg/dL, direct bilirubin 0.3 mg/dL, alkaline phosphatase 34 U/L, with INR 0.7. Viral serology for acute hepatitis B, C, E, cytomegalovirus, Epstein-Barr virus, and varicella zoster virus was negative. She was immune to hepatitis A. Her antinuclear antibody was positive. Her anti-Smith antibody, anti-smooth muscle antibody, HFE gene mutation, ceruloplasmin, alpha-1 antitrypsin serologies were within normal references. An abdomen sonogram showed fatty infiltration. Liver biopsy showed moderate to severe portal inflammation and marked lobular disarray. Portal and lobular inflammatory infiltrates consisted of a mixture of histiocytes, lymphocytes, plasma cells, eosinophils, and neutrophils with centrilobular necrosis and focal bridging necrosis, and necro-inflammation. After 6 weeks of follow-up, the patient improved physically, and the abdomen pain resolved. Ginseng has been widely used in the Chinese community as medicinal herb for a variety of conditions for decades. However, proper research has never been done regarding its pharmacokinetics, efficacy, and safety issues. In our case report, the idiosyncratic DILI resulted from ingestion of ginseng as herbal supplementation for premenopausal symptoms. Physicians should be aware of and suspect DILI in any patient with acute liver injury, and patients should be reminded that all medications and supplements have a potential to cause DILI.
format Online
Article
Text
id pubmed-6120378
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-61203782018-09-05 Ginseng-Related Drug-Induced Liver Injury Lin, Kyawzaw Lin, Aung Naing Linn, Sandar Hlaing, Pwint Phyu Vasudevan, Viswanath Reddy, Madhavi Case Rep Gastroenterol Single Case Ginseng is commonly used as a medicinal herb for memory and concentration and general well-being. Drug-induced liver injury (DILI) is one of the most challenging disorders and trending events in the United States which are related to body building and weight loss supplements. Currently, herbal and dietary supplementation is the second most common cause of DILI. Here, we report on a 45-year-old healthy Chinese woman who presented with dull intermittent left upper quadrant abdomen pain for a month. Upon thorough history taking, she had been taking ginseng tea and supplementation for her menopausal symptoms for almost 3 months. Physical examination was unremarkable except mild tenderness in left upper quadrant of the abdomen. Liver function test showed aspartate transaminase (AST) 717 U/L, alanine transaminase (ALT) 343 U/L, total bilirubin 5 mg/dL, direct bilirubin 3.3 mg/dL, alkaline phosphatase 182 U/L, with international normalized ratio (INR) 1.2. Prior liver enzymes (6 months earlier) showed AST 21 U/L, ALT 18 U/L, total bilirubin 0.8 mg/dL, direct bilirubin 0.3 mg/dL, alkaline phosphatase 34 U/L, with INR 0.7. Viral serology for acute hepatitis B, C, E, cytomegalovirus, Epstein-Barr virus, and varicella zoster virus was negative. She was immune to hepatitis A. Her antinuclear antibody was positive. Her anti-Smith antibody, anti-smooth muscle antibody, HFE gene mutation, ceruloplasmin, alpha-1 antitrypsin serologies were within normal references. An abdomen sonogram showed fatty infiltration. Liver biopsy showed moderate to severe portal inflammation and marked lobular disarray. Portal and lobular inflammatory infiltrates consisted of a mixture of histiocytes, lymphocytes, plasma cells, eosinophils, and neutrophils with centrilobular necrosis and focal bridging necrosis, and necro-inflammation. After 6 weeks of follow-up, the patient improved physically, and the abdomen pain resolved. Ginseng has been widely used in the Chinese community as medicinal herb for a variety of conditions for decades. However, proper research has never been done regarding its pharmacokinetics, efficacy, and safety issues. In our case report, the idiosyncratic DILI resulted from ingestion of ginseng as herbal supplementation for premenopausal symptoms. Physicians should be aware of and suspect DILI in any patient with acute liver injury, and patients should be reminded that all medications and supplements have a potential to cause DILI. S. Karger AG 2018-08-21 /pmc/articles/PMC6120378/ /pubmed/30186097 http://dx.doi.org/10.1159/000490525 Text en Copyright © 2018 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Lin, Kyawzaw
Lin, Aung Naing
Linn, Sandar
Hlaing, Pwint Phyu
Vasudevan, Viswanath
Reddy, Madhavi
Ginseng-Related Drug-Induced Liver Injury
title Ginseng-Related Drug-Induced Liver Injury
title_full Ginseng-Related Drug-Induced Liver Injury
title_fullStr Ginseng-Related Drug-Induced Liver Injury
title_full_unstemmed Ginseng-Related Drug-Induced Liver Injury
title_short Ginseng-Related Drug-Induced Liver Injury
title_sort ginseng-related drug-induced liver injury
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120378/
https://www.ncbi.nlm.nih.gov/pubmed/30186097
http://dx.doi.org/10.1159/000490525
work_keys_str_mv AT linkyawzaw ginsengrelateddruginducedliverinjury
AT linaungnaing ginsengrelateddruginducedliverinjury
AT linnsandar ginsengrelateddruginducedliverinjury
AT hlaingpwintphyu ginsengrelateddruginducedliverinjury
AT vasudevanviswanath ginsengrelateddruginducedliverinjury
AT reddymadhavi ginsengrelateddruginducedliverinjury